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An 8-month-old Japanese boy was diagnosed with acute monocytic leukaemia (AMoL, M5b 
according to FAB classifications) with t(9;11)(p22;q23). Abdominal magnetic resonance 
imaging (MRI) demonstrated a homogeneous solid mass (25!36!25 mm) in the upper pole of 
the left kidney (panel A) and a cortical mass (diameter, 10 mm) in the lower portion of the right 
kidney. Renal masses were hypointense relative to renal cortex on both T1- and T2-weighted 
imaging, with weak homogeneous gadolinium enhancement. Histopathological examination of 
cream-coloured biopsy sections revealed diffuse infiltration of cells surrounding intact 
glomeruli in the renal parenchyma (panel B). Predominant monoblastic features were shown on 
imprints (panel C). Fluorescence in situ hybridisation and Southern blot analyses identified the 
rearrangement of MLL gene, confirming a diagnosis of monoblastic sarcoma of the kidney. 
Monoblastic sarcoma is a less-common form of myeloid sarcoma, and may precede or occur 
concurrently with AMoL with 11q23/MLL rearrangements. Any part of the body can be 
involved, but renal involvement is rare and no infant cases have previously been reported. In 
cases such as the present, pathologically confirmed diagnosis is essential to establish 
appropriate therapeutic strategies, since the differential diagnosis could include primary renal 
tumours. 
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